Safety, Blood Levels and Effects of AUT00201 in Patients With MEAK
NCT05873062
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
6
Enrollment
INDUSTRY
Sponsor class
Conditions
Myoclonus Epilepsies, Progressive
Interventions
DRUG:
AUT00201
DRUG:
Placebo
Sponsor
Autifony Therapeutics Limited